"
Page
Discussion
View source
History
teams
Log in
 
Team:Paris/August 18
From 2008.igem.org
Project
Analysis
Construction
Characterization
Perspectives
← Yesterday
↓ Calendar ↑
Tomorrow →
June
Mo
Tu
We
Th
Fr
Sa
Su
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
 
 
 
 
 
 
July
Mo
Tu
We
Th
Fr
Sa
Su
 
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
 
 
 
August
Mo
Tu
We
Th
Fr
Sa
Su
 
 
 
 
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
September
Mo
Tu
We
Th
Fr
Sa
Su
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
 
 
 
 
 
October
Mo
Tu
We
Th
Fr
Sa
Su
 
 
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
 
 
November
Mo
Tu
We
Th
Fr
Sa
Su
 
 
 
 
 
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Contents
1 Analysis of the cloning of OmpR* and EnvZ*
1.1 PCR screening
1.2 Minipreps & Stocks
2 Construction of rbs-LasR-dble ter
2.1 Miniprep and stock glycerol of L151 (rbs-LasR - Double terminator)
3 Construction of : promotor-rbs-LasR - Dble ter
3.1 Digestion
3.1.1 Measurement of the concentration of MPs 162
3.1.2 Digestion
3.1.3 Gel Extraction
3.2 Ligation
4 Culture of stable strains with biobricks 2008
Analysis of the cloning of OmpR* and EnvZ*
PCR screening
positive control: S158 (pSB3K3)
negative control: no template
screening PCR programm
elongation time: 1 min 30
primers: O18 & O19
Reaction mixture (25 µL total volume)
12,5 µL Quick load PCR Mix
0,5 µL O18
0,5 µL O19
12 µL water
Minipreps & Stocks
We wanted to analyse the transformants of the ligations L133 (OmpR* in pSB1A2) and L134 (EnvZ* in pSB1A2) from the experience of august 9th/11th.
3 clones of L133 and 3 clones of L134 were analysed.
Each clone tested was then cultured in 7,5 mL LB + ampicilline.
Construction of rbs-LasR-dble ter
Miniprep and stock glycerol of L151 (rbs-LasR - Double terminator)
Protocol stocks
Protocol minprep
Miniprep number
Stock number
Ligation name
Antibio
Biobricks
Description
MP162.1
S162.1
L151.1
Kan
rbs-LasR - Double terminator
MP162.2
S162.2
L151.2
MP162.3
S162.3
L151.3
Construction of : promotor-rbs-LasR - Dble ter
Digestion
Measurement of the concentration of MPs 162
Miniprep Name
Concentration (µg/mL)
Ratio 260/280
MP162.1
151
1.71
MP162.2
172
1.73
MP162.3
149
1.73
Digestion
Protocol
Digestion name
Template DNA
Enzymes
Volume of DNA
D165
MP162.2
XbaI - PstI
5.81 µL
Gel Extraction
Gel Extraction of D165
Protocol
Well
Sample
Expected size
Measured size
1
1kb ladder
2
MP162.2
2855
3000
3
no sample
4
D165.2
2057 / 798
2000 / 800
5
no sample
6
100pb ladder
Ligation
Protocol
Ligation Name
Vector Name
Volume Vector (µL)
Insert
Volume Insert (µL)
L153
D123.1
1.54
D165
1.69
L154
D103.2
1.14
D165
1.68
Control L153
D123.1
1.54
-
-
Control L154
D103.2
1.14
-
-
Culture of stable strains with biobricks 2008
Protocol
Biobrick Name
Part
Description
B0032 in pSB1A2
rbs (efficiency=0.3)
E0422 in pSB1A2
ECFP (LVA+)
E0420 in pSB1A2
ECFP (LVA-)
E0430 in pSB1A2
EYFP (LVA-)
E0432 in pSB1A2
EYFP (LVA+)
I732078 in pSB1A3
mRFP1 (LVA+)
I13507 in pSB1A2
mRFP1 (LVA-)
Retrieved from " http://2008.igem.org/Team:Paris/August_18 "
Recent changes
What links here
Related changes
Special pages
My preferences
Printable version
Permanent link
Privacy policy
Disclaimers
